Envestnet Asset Management Inc. Sells 2,811 Shares of athenahealth, Inc. (ATHN)

Envestnet Asset Management Inc. reduced its stake in athenahealth, Inc. (NASDAQ:ATHN) by 9.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,366 shares of the health services provider’s stock after selling 2,811 shares during the period. Envestnet Asset Management Inc. owned approximately 0.07% of athenahealth worth $3,278,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ATHN. Advisor Group Inc. boosted its position in shares of athenahealth by 2.8% during the second quarter. Advisor Group Inc. now owns 1,744 shares of the health services provider’s stock valued at $244,000 after buying an additional 47 shares during the last quarter. Teacher Retirement System of Texas boosted its position in shares of athenahealth by 2.2% during the second quarter. Teacher Retirement System of Texas now owns 3,156 shares of the health services provider’s stock valued at $444,000 after buying an additional 67 shares during the last quarter. State of Wisconsin Investment Board boosted its position in shares of athenahealth by 0.9% during the second quarter. State of Wisconsin Investment Board now owns 7,868 shares of the health services provider’s stock valued at $1,106,000 after buying an additional 70 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of athenahealth by 7.7% during the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after buying an additional 84 shares during the last quarter. Finally, Evercore Wealth Management LLC boosted its position in shares of athenahealth by 1.3% during the second quarter. Evercore Wealth Management LLC now owns 7,094 shares of the health services provider’s stock valued at $997,000 after buying an additional 94 shares during the last quarter.

athenahealth, Inc. (NASDAQ:ATHN) opened at $131.47 on Wednesday. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.67 and a quick ratio of 1.67. athenahealth, Inc. has a 12 month low of $92.38 and a 12 month high of $158.66. The company has a market capitalization of $5,276.33, a PE ratio of 111.74, a PEG ratio of 4.95 and a beta of 1.57.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings data on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, topping the consensus estimate of $0.50 by $0.06. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The firm had revenue of $304.60 million for the quarter, compared to the consensus estimate of $310.52 million. During the same quarter last year, the company earned $0.60 earnings per share. The business’s revenue for the quarter was up 10.1% compared to the same quarter last year. research analysts expect that athenahealth, Inc. will post 1.2 EPS for the current fiscal year.

In related news, Director Brandon H. Hull sold 800 shares of the stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $132.97, for a total transaction of $106,376.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Bradford Kyle Armbrester sold 1,000 shares of the stock in a transaction dated Friday, October 27th. The stock was sold at an average price of $128.56, for a total value of $128,560.00. The disclosure for this sale can be found here. Insiders have sold 9,283 shares of company stock valued at $1,175,908 in the last quarter. 3.20% of the stock is currently owned by company insiders.

Several equities research analysts recently commented on the company. Deutsche Bank assumed coverage on athenahealth in a research report on Friday, December 8th. They set a “hold” rating and a $145.00 price objective on the stock. BidaskClub raised athenahealth from a “strong sell” rating to a “sell” rating in a research report on Saturday, December 2nd. Oppenheimer reaffirmed a “buy” rating and set a $184.00 price objective on shares of athenahealth in a research report on Friday, October 20th. Robert W. Baird reaffirmed a “buy” rating and set a $170.00 price objective on shares of athenahealth in a research report on Thursday, August 31st. Finally, Canaccord Genuity reaffirmed a “hold” rating and set a $123.00 price objective (down from $144.00) on shares of athenahealth in a research report on Monday, October 23rd. Two investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and eleven have given a buy rating to the stock. athenahealth currently has an average rating of “Hold” and a consensus target price of $143.29.

TRADEMARK VIOLATION NOTICE: “Envestnet Asset Management Inc. Sells 2,811 Shares of athenahealth, Inc. (ATHN)” was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The legal version of this report can be accessed at https://ledgergazette.com/2017/12/13/envestnet-asset-management-inc-sells-2811-shares-of-athenahealth-inc-athn.html.

athenahealth Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc. (NASDAQ:ATHN).

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply